Shanghai Junshi Biosciences Co., Ltd.
1877.HKFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
253
Cost of Revenue
53
Gross Profit
200
Gross Margin
78.9%
Operating Income
-174
Operating Margin
-68.7%
Net Income
-167
Net Margin
-65.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-122
EBITDA Margin
-48.0%
2023
12/31/2023
Revenue
195
Cost of Revenue
82
Gross Profit
109
Gross Margin
55.6%
Operating Income
-319
Operating Margin
-163.2%
Net Income
-297
Net Margin
-151.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-280
EBITDA Margin
-143.6%
2022
12/31/2022
Revenue
189
Cost of Revenue
68
Gross Profit
121
Gross Margin
63.8%
Operating Income
-358
Operating Margin
-189.3%
Net Income
-310
Net Margin
-164.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-328
EBITDA Margin
-173.4%
2021
12/31/2021
Revenue
523
Cost of Revenue
164
Gross Profit
360
Gross Margin
68.7%
Operating Income
-77
Operating Margin
-14.7%
Net Income
-93
Net Margin
-17.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-62
EBITDA Margin
-11.8%
2020
12/31/2020
Revenue
207
Cost of Revenue
48
Gross Profit
159
Gross Margin
76.6%
Operating Income
-217
Operating Margin
-104.6%
Net Income
-217
Net Margin
-104.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
-205
EBITDA Margin
-98.8%